A01084 Summary:

BILL NOA01084
 
SAME ASNo Same As
 
SPONSORSteck
 
COSPNSRZaccaro, Bores, Brown K
 
MLTSPNSR
 
Add §19.46, Ment Hyg L
 
Provides free fentanyl test strips to individuals at specified distribution facilities; requires a public awareness campaign on the dangers of fentanyl and the provision of the test strips.
Go to top    

A01084 Actions:

BILL NOA01084
 
01/08/2025referred to alcoholism and drug abuse
Go to top

A01084 Committee Votes:

Go to top

A01084 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A01084 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A1084
 
SPONSOR: Steck
  TITLE OF BILL: An act to amend the mental hygiene law, in relation to establishing the fentanyl test strip program   PURPOSE: To expand access to fentanyl and xylazine test strips, preventing acci- dental overdose and death of unsuspecting illicit substance users.   SUMMARY OF PROVISIONS: Section 1. The mental hygiene law is amended by adding a new section to read as follows: §19.46 Fentanyl and xylazine test strip program. 1. The commissioner shall establish a program where individuals may receive, free of charge, fentanyl test strips to detect the presence of fentanyl and xylazine test strips to detect the presence of xylazine. The following facilities may apply to distribute such test strips: (a) hospital emergency rooms; (b) addiction treatment facilities; (c) facilities for substance use disorder programs; (d) homeless shelters; (e) urgent care centers; (f) mobile medication units; (g) treatment facilities as defined in subdivision five of section 22.09 of this title; and (h) any other setting, as determined by the office, which is routinely accessed by individuals with substance use disorder. 2. Individuals shall not be targeted by law enforcement when they are obtaining test strips at the.facilities. 3. The commissioner, in cooperation with the commissioner of the depart- ment of health, shall develop and conduct a public awareness and educa- tional campaign on the dangers of fentanyl and xylazine. The campaign shall detail where fentanyl and xylazine can be found and the availabil- ity of the free test strips at the facilities referenced. Section 2: Effective date.   JUSTIFICATION: Overdose deaths involving fentanyl has risen dramatically in recent years. According to the DEA, in 2022 "Fentanyl saturates the illegal drug supply in New York City and is a factor in roughly 80% of overdose deaths. Even casual or occasional illegal drug use could be fatal, and with an explosion in counterfeit pills containing fentanyl, a single tablet purchased online or on social media could be deadly." "In Decem- ber of 2022, the DEA alerted the public to a sharp nationwide increase in the lethality of fentanyl-laced fake prescription pills. DEA labora- tory testing in 2022 revealed that six out of ten fentanyllaced, fake prescription pills contained a potentially lethal dose of fentanyl. This is an increase from DEA's announcement in 2021 that four out of ten fentanyl-laced, fake prescription pills contain a potentially deadly dose." In October of 2022, the DEA reported "Xylazine, reported as an adulter- ant in an increasing number of illicit drug mixtures, has also been detected in a growing number of overdose deaths. It is commonly encount- ered in combination with fentanyl but has also been detected in mixtures containing cocaine, heroin, and a variety of other drugs. However, xylazine is most frequently reported in combinations with two or more substances present" and "The presence of xylazine in illicit drug combi- nations and its detection in fatal overdoses may be more widespread than reported as a number of jurisdictions across the country may not include xylazine in forensic laboratory or toxicology testing." Fentanyl and xylazine, both separately and in combination, can be found in cocaine, heroin, MDMA (molly), and a variety of other substances. Though the effects of fentanyl can be reserved with naloxone (Narcan), xylazine is a non-opioid agent and its effects cannot be reserved with naloxone. This program provides for illicit substance users to access fentanyl and xylazine test strips anonymously and free of charge, and not to be targeted by law enforcement when accessing them. It also establishes a public awareness campaign to educate the public about the dangers of fentanyl and xylazine, where fentanyl and xylazine can be found, and where to go for test strips.   LEGISLATIVE HISTORY: New bill   FISCAL IMPLICATIONS: To be determined.   EFFECTIVE DATE: This act shall take effect immediately.
Go to top

A01084 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1084
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                     January 8, 2025
                                       ___________
 
        Introduced  by M. of A. STECK, ZACCARO, BORES, K. BROWN -- read once and
          referred to the Committee on Alcoholism and Drug Abuse
 
        AN ACT to amend the mental hygiene law, in relation to establishing  the
          fentanyl test strip program
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The mental hygiene law is amended by adding a  new  section
     2  19.46 to read as follows:
     3  § 19.46 Fentanyl test strip program.
     4    1.  The commissioner shall establish a program whereby individuals may
     5  receive, free of charge, fentanyl test strips to detect the presence  of
     6  fentanyl. The following facilities may apply to distribute such fentanyl
     7  test strips:
     8    (a) hospital emergency rooms;
     9    (b) addiction treatment facilities;
    10    (c) facilities for substance use disorder programs;
    11    (d) homeless shelters;
    12    (e) urgent care centers;
    13    (f) mobile medication units;
    14    (g)  treatment  facilities  as  defined in subdivision five of section
    15  22.09 of this title; and
    16    (h) any other setting, as determined by the office, which is routinely
    17  accessed by individuals with a substance use disorder.
    18    2. Individuals shall not be targeted by law enforcement when they  are
    19  obtaining  the fentanyl test strips at the facilities pursuant to subdi-
    20  vision one of this section.
    21    3. The commissioner, in  cooperation  with  the  commissioner  of  the
    22  department  of  health, shall develop and conduct a public awareness and
    23  educational campaign on the dangers of  fentanyl.  Such  campaign  shall
    24  detail  where  fentanyl  may  be  found and the availability of the free
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD03052-01-5

        A. 1084                             2
 
     1  fentanyl test strips at the facilities referenced in subdivision one  of
     2  this section.
     3    § 2. This act shall take effect on the one hundred eightieth day after
     4  it  shall have become a law. Effective immediately, the addition, amend-
     5  ment and/or repeal of any rule or regulation necessary for the implemen-
     6  tation of this act on its effective date are authorized to be  made  and
     7  completed on or before such effective date.
Go to top

A01084 LFIN:

 NO LFIN
Go to top

A01084 Chamber Video/Transcript:

Go to top